$HCSG
HEALTHCARE SERVICES GROUP INC

2013 Q2 Form 10-Q Financial Statement

#000073101213000066 Filed on July 25, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $273.6M $267.1M
YoY Change 2.43% 26.29%
Cost Of Revenue $234.6M $230.2M
YoY Change 1.91% 26.67%
Gross Profit $39.00M $36.90M
YoY Change 5.69% 23.98%
Gross Profit Margin 14.25% 13.82%
Selling, General & Admin $19.36M $18.52M
YoY Change 4.53% 19.42%
% of Gross Profit 49.65% 50.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.300M $1.300M
YoY Change 0.0% 30.0%
% of Gross Profit 3.33% 3.52%
Operating Expenses $19.36M $18.52M
YoY Change 4.53% 19.42%
Operating Profit $19.64M $18.38M
YoY Change 6.86% 28.93%
Interest Expense $200.0K -$100.0K
YoY Change -300.0% -120.0%
% of Operating Profit 1.02% -0.54%
Other Income/Expense, Net
YoY Change
Pretax Income $19.86M $18.28M
YoY Change 8.61% 24.23%
Income Tax $6.925M $6.963M
% Of Pretax Income 34.87% 38.08%
Net Earnings $12.93M $11.32M
YoY Change 14.25% 15.18%
Net Earnings / Revenue 4.73% 4.24%
Basic Earnings Per Share $0.19 $0.17
Diluted Earnings Per Share $0.19 $0.17
COMMON SHARES
Basic Shares Outstanding 68.60M shares 67.30M shares
Diluted Shares Outstanding 69.37M shares 68.23M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $85.19M $77.00M
YoY Change 10.63% 0.92%
Cash & Equivalents $63.16M $55.60M
Short-Term Investments $22.03M $21.40M
Other Short-Term Assets $9.800M $10.50M
YoY Change -6.67% 69.35%
Inventory $28.60M $27.10M
Prepaid Expenses $9.767M $10.48M
Receivables $165.7M $135.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $289.3M $250.3M
YoY Change 15.57% 13.22%
LONG-TERM ASSETS
Property, Plant & Equipment $10.20M $10.13M
YoY Change 0.7% 23.56%
Goodwill $16.96M $16.96M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.00K $38.00K
YoY Change 0.0% -99.83%
Total Long-Term Assets $66.11M $62.10M
YoY Change 6.46% 7.44%
TOTAL ASSETS
Total Short-Term Assets $289.3M $250.3M
Total Long-Term Assets $66.11M $62.10M
Total Assets $355.4M $312.4M
YoY Change 13.76% 12.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.24M $20.86M
YoY Change 49.75% 115.05%
Accrued Expenses $39.00M $34.90M
YoY Change 11.75% 27.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $75.27M $59.44M
YoY Change 26.63% 59.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $36.60M $30.90M
YoY Change 18.45% 12.77%
Total Long-Term Liabilities $36.60M $30.90M
YoY Change 18.45% 12.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $75.27M $59.44M
Total Long-Term Liabilities $36.60M $30.90M
Total Liabilities $111.9M $90.40M
YoY Change 23.78% 39.94%
SHAREHOLDERS EQUITY
Retained Earnings $132.0M $125.0M
YoY Change 5.58%
Common Stock $122.9M $112.5M
YoY Change 9.21%
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.37M $15.61M
YoY Change -27.12%
Treasury Stock Shares 1.899M shares 2.624M shares
Shareholders Equity $243.5M $222.1M
YoY Change
Total Liabilities & Shareholders Equity $355.4M $312.4M
YoY Change 13.76% 12.02%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $12.93M $11.32M
YoY Change 14.25% 15.18%
Depreciation, Depletion And Amortization $1.300M $1.300M
YoY Change 0.0% 30.0%
Cash From Operating Activities $19.00M $18.00M
YoY Change 5.56% 87.5%
INVESTING ACTIVITIES
Capital Expenditures -$700.0K -$1.000M
YoY Change -30.0% -16.67%
Acquisitions
YoY Change
Other Investing Activities $200.0K -$300.0K
YoY Change -166.67% -200.0%
Cash From Investing Activities -$500.0K -$1.300M
YoY Change -61.54% 62.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.10M -9.300M
YoY Change 8.6% -7.0%
NET CHANGE
Cash From Operating Activities 19.00M 18.00M
Cash From Investing Activities -500.0K -1.300M
Cash From Financing Activities -10.10M -9.300M
Net Change In Cash 8.400M 7.400M
YoY Change 13.51% -716.67%
FREE CASH FLOW
Cash From Operating Activities $19.00M $18.00M
Capital Expenditures -$700.0K -$1.000M
Free Cash Flow $19.70M $19.00M
YoY Change 3.68% 75.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1906000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
548000 shares
CY2012Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
140218000 USD
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4479000 USD
CY2013Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
165700000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22810000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
31238000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18477000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19427000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
127000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
44000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
122148000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
113495000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1011000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1128000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1196000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1144000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3671000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3970000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
542000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
542000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1084000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1084000 USD
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
552000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
585000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
596000 shares
CY2013Q2 us-gaap Assets
Assets
355410000 USD
CY2012Q4 us-gaap Assets
Assets
331183000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
289301000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
267846000 USD
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
7284000 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5164000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
16000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68949000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63160000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55599000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38639000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5789000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16960000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5550000 shares
CY2013Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16750
CY2013Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16625
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70407000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70036000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70407000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70036000 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
704000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19709000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12827000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27804000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11303000 USD
us-gaap Cost Of Services
CostOfServices
457701000 USD
CY2012Q2 us-gaap Cost Of Services
CostOfServices
230206000 USD
CY2013Q2 us-gaap Cost Of Services
CostOfServices
234602000 USD
us-gaap Cost Of Services
CostOfServices
469793000 USD
CY2012Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
18237000 USD
CY2013Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
20033000 USD
CY2012Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
17831000 USD
CY2013Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
19757000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12535000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11215000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
537000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
575000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2707000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2528000 USD
CY2013Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-06-14
CY2013Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-03-15
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
22931000 USD
CY2013Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-02-22
CY2013Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-05-10
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.28
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28823000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31997000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5982000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4948000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1128000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1051000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10078000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11162000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
0 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1179000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
765000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
197000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
297000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
569000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1112000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15281000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15281000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5203000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4119000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
16955000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
16955000 USD
CY2012 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19858000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
32066000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18283000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38815000 USD
us-gaap Income Loss From Extraordinary Items Net Of Tax Per Basic Share
IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Extraordinary Items Net Of Tax Per Basic Share
IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare
-0.01
CY2013Q2 us-gaap Income Loss From Extraordinary Items Net Of Tax Per Basic Share
IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare
0.00
CY2012Q2 us-gaap Income Loss From Extraordinary Items Net Of Tax Per Basic Share
IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare
0.00
us-gaap Share Based Compensation
ShareBasedCompensation
1196000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6925000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10928000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12167000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6963000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8531000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9782000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
26812000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
7891000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2573000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
2360000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
2922000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1906000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
8454000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
10759000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
536000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-1989000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1085000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4630000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
0 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-3740000 USD
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
1137000 USD
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
3485000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
966000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
835000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.028
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.036
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
932000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
771000 shares
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
75268000 USD
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
346000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
303000 USD
CY2012Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
-95000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1558000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1253000 USD
CY2013Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
219000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
331183000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
355410000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
67664000 USD
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2014-06-30
CY2013Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
57000000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2336000 USD
CY2013Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2441000 USD
CY2013Q2 us-gaap Marketable Securities
MarketableSecurities
22026000 USD
CY2012Q4 us-gaap Marketable Securities
MarketableSecurities
21322000 USD
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
22026000 USD
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
21322000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17070000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18029000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2699000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7607000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13980000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27382000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
12933000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
11320000 USD
us-gaap Net Income Loss
NetIncomeLoss
27887000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.389
us-gaap Net Income Loss
NetIncomeLoss
19899000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19899000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
27887000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12933000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11320000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19899000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
27887000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
12933000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11320000 USD
CY2013Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
2502000 USD
CY2012Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1823000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2013Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
48 state
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3526000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3081000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-72000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-17000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-83000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-106000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-190000 USD
CY2012Q4 us-gaap Other Inventory
OtherInventory
28675000 USD
CY2013Q2 us-gaap Other Inventory
OtherInventory
28648000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21803000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22931000 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11415000 USD
CY2013Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11516000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6362000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4597000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1702000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1825000 USD
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9767000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8682000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
59000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3450000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15784000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
3000000 USD
CY2013Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
3000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14871000 USD
CY2012Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
4274000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
150000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4680000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2664000 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29630000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10203000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10272000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.392
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28749000 USD
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
315000 USD
CY2013Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
310000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1350000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
650000 USD
CY2013Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
16000 USD
CY2012Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
41000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
16000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
224000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
127042000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131998000 USD
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
267108000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
527715000 USD
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
273604000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
547508000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40153000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18524000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39506000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19363000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1144000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
49000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
18.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
564000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2769000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2632000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.18
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.46
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.50
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
7110000 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
11374000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11794000 USD
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0 USD
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-82000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y9M17D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
378000 shares
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
53000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
363000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1842000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1250000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4680000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
229570000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
243520000 USD
us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
0 USD
us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
-82000 USD
CY2012Q2 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
-26000 USD
CY2013Q2 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
0 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1983000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1899000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates in Financial Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing financial statements in conformity with U.S. GAAP, we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are used for, but not limited to, our allowance for doubtful accounts, accrued insurance claims, asset valuations and review for potential impairment, and deferred taxes. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information. We regularly evaluate this information to determine if it is necessary to update the basis for our estimates and to compensate for known changes.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69366000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68228000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68155000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69370000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68599000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67189000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67296000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68531000 shares
CY2012Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
6850000 USD
CY2012Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
15712000 USD
CY2013Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
16589000 USD
CY2013Q2 hcsg Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
8000000 USD
CY2012Q4 hcsg Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
12134000 USD
CY2012Q4 hcsg Available For Sale Securities Debt Maturities After Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue
4024000 USD
CY2013Q2 hcsg Available For Sale Securities Debt Maturities After Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue
6742000 USD
CY2012Q2 hcsg Common Stock Weighted Average Dividends Per Share Cash Paid
CommonStockWeightedAverageDividendsPerShareCashPaid
0.16
hcsg Common Stock Weighted Average Dividends Per Share Cash Paid
CommonStockWeightedAverageDividendsPerShareCashPaid
0.33
CY2013Q2 hcsg Common Stock Weighted Average Dividends Per Share Cash Paid
CommonStockWeightedAverageDividendsPerShareCashPaid
0.17
hcsg Common Stock Weighted Average Dividends Per Share Cash Paid
CommonStockWeightedAverageDividendsPerShareCashPaid
0.32
CY2013Q2 hcsg Debt Securities Amortized Cost
DebtSecuritiesAmortizedCost
21953000 USD
CY2012Q4 hcsg Debt Securities Amortized Cost
DebtSecuritiesAmortizedCost
21111000 USD
CY2012Q4 hcsg Debt Securities Gross Unrealized Gains
DebtSecuritiesGrossUnrealizedGains
220000 USD
CY2013Q2 hcsg Debt Securities Gross Unrealized Gains
DebtSecuritiesGrossUnrealizedGains
130000 USD
CY2012Q4 hcsg Debt Securities Gross Unrealized Losses
DebtSecuritiesGrossUnrealizedLosses
9000 USD
CY2013Q2 hcsg Debt Securities Gross Unrealized Losses
DebtSecuritiesGrossUnrealizedLosses
57000 USD
hcsg Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans
DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans
-2405000 USD
hcsg Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans
DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans
-1305000 USD
hcsg Description For Terms Of Service Agreement
DescriptionForTermsOfServiceAgreement
Our agreements with clients typically provide for a one year service term, cancelable by either party upon 30 to 90 days’ notice after the initial 90-day period.
CY2012Q4 hcsg Housekeeping Equipment And Office Furniture Gross
HousekeepingEquipmentAndOfficeFurnitureGross
26098000 USD
CY2013Q2 hcsg Housekeeping Equipment And Office Furniture Gross
HousekeepingEquipmentAndOfficeFurnitureGross
26879000 USD
hcsg Increase Decrease In Deferred Compensation Funding
IncreaseDecreaseInDeferredCompensationFunding
1926000 USD
hcsg Increase Decrease In Deferred Compensation Funding
IncreaseDecreaseInDeferredCompensationFunding
1078000 USD
hcsg Line Of Credit Facility Increase Decrease Remaining Borrowing Capacity
LineOfCreditFacilityIncreaseDecreaseRemainingBorrowingCapacity
-43520000 USD
hcsg Line Of Credit Facility Number Of Financial Covenants
LineOfCreditFacilityNumberOfFinancialCovenants
2 financial_covenant
CY2013Q2 hcsg Number Of States Subsidiary Operates
NumberOfStatesSubsidiaryOperates
2 state
CY2013Q2 hcsg Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
CY2012Q2 hcsg Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice
17.50
CY2011Q3 hcsg Percentage Of Reduction To Medicare Payments To Nursing Centers
PercentageOfReductionToMedicarePaymentsToNursingCenters
0.111
hcsg Percentage Of Revenue And Income Earned In One Geographic Segment
PercentageOfRevenueAndIncomeEarnedInOneGeographicSegment
0.99
hcsg Period Of Amortization Of Inventories And Supplies
PeriodOfAmortizationOfInventoriesAndSupplies
P24M
hcsg Service Agreements Duration Of Service
ServiceAgreementsDurationOfService
P1Y
hcsg Service Agreements Initial Period
ServiceAgreementsInitialPeriod
P90D
hcsg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodTotalFairValue
1870000 USD
hcsg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodTotalFairValue
1897000 USD
CY2012Q2 hcsg Share Based Compensation Arrangement By Share Based Payment Award Options Grants Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsGrantDateFairValue
2438000 USD
CY2013Q2 hcsg Share Based Compensation Arrangement By Share Based Payment Award Options Grants Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsGrantDateFairValue
3412000 USD
CY2013Q2 hcsg Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice
23.50
hcsg Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice
17.50
hcsg Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice
23.50
hcsg Unrealized Gain Loss On Securities Related To Deferred Compensation Fund
UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund
937000 USD
hcsg Unrealized Gain Loss On Securities Related To Deferred Compensation Fund
UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund
759000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000731012
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69785000 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE SERVICES GROUP INC

Files In Submission

Name View Source Status
0000731012-13-000066-index-headers.html Edgar Link pending
0000731012-13-000066-index.html Edgar Link pending
0000731012-13-000066.txt Edgar Link pending
0000731012-13-000066-xbrl.zip Edgar Link pending
ceosection302certification.htm Edgar Link pending
cfosection302certification.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
hcsg-20130630.xml Edgar Link completed
hcsg-20130630.xsd Edgar Link pending
hcsg-20130630_cal.xml Edgar Link unprocessable
hcsg-20130630_def.xml Edgar Link unprocessable
hcsg-20130630_lab.xml Edgar Link unprocessable
hcsg-20130630_pre.xml Edgar Link unprocessable
hcsg10qq22013.htm Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
section906certificationq22.htm Edgar Link pending
Show.js Edgar Link pending